Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Recap by typeshit. Full story at www.polskieradio.pl.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
Semafor reports South Africa has Africa's highest adult obesity rate at 30%, yet branded weight loss drugs remain too expensive for most people there.
A Polish Radio piece argues that Ozempic and similar weight-loss drugs are creating health problems that get little attention.
Dr. Regina DePietro of MU Health Care says unapproved injectables sold "for research" lack safety checks, and the products could be fake or useless.
Loading…